New joint venture hemodialysis unit on Cleveland’s Eastside offers patients both state-of-the-art clinical and comfort features.
Nocturnal in-center intermittent hemodialysis has clinical advantages and is an alternative that clinicians should not overlook. Longer treatment more efficiently removes small and mid-sized molecules, improves nutritional status, better controls anemia and hyperphosphatemia and reduces blood pressure and cardiovascular mortality. Nighttime dialysis also disturbs daytime eating patterns less. Patients report increased energy and improved daytime cognition.
The proof of concept of renal transplantation in HIV-positive recipients and, more recently, of using organs from HIV-positive donors, means that additional HIV-positive end-stage renal disease patients will be eligible for transplantation and will experience benefits similar to those of non-infected patients.
A 74-year-old patient arrived in the emergency department with shortness of breath, a history of diabetes and hypertension, and clinical signs of acute kidney injury. What caused the damage? Renal pathology using light microscopy, immunofluorescence and electron microscopy provided clues, but it took some non-standard techniques to reach a confident final diagnosis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The presence of chronic obstructive pulmonary disease in patients with chronic kidney disease greatly increases the risk of death, a Cleveland Clinic study has found. The results demonstrate the importance of closely monitoring chronic kidney disease patients with respiratory comorbidities.
George Thomas, MD, explains the factors and risks associated with resistant hypertension and outlines management techniques for care at home and treatment resources provided by Cleveland Clinic.
With sudden cardiac death an increasing risk as kidney disease progresses, CKD patients would seem to gain from implantable defibrillators. But a Cleveland Clinic analysis shows that the device’s mortality reductions don’t extend to patients in end-stage CKD.
A Cleveland Clinic analysis shows heart disease and cancer are main causes of death in non-dialysis-dependent chronic kidney disease patients, with reduced renal function linked to higher risk for cardiovascular mortality. Blacks with mild to moderate CKD have higher risk of cardiovascular deaths than do whites.
Should clinicians try to aggressively lower BP in older hypertensive patients to “optimal levels,” i.e., less than 120/80 mm Hg? The results of a landmark clinical trial say yes.
A recent study has found that in patients with stage 3 to 4 chronic kidney disease, mortality levels are lowest when serum potassium levels are kept between 4 and 5 mmol/L.